Broad Complex Tachycardia (BCT)

Introduction

Broad Complex Tachycardia (BCT) is a term used to describe a rapid heart rate (typically over 100 beats per minute) that originates from the ventricles or involves an abnormal conduction pathway, resulting in a QRS complex duration greater than 120 milliseconds. It is crucial to differentiate between life-threatening and benign causes of BCT, as it often requires urgent medical intervention.

Causes of BCT

There are two primary categories of Broad Complex Tachycardia: 1. Ventricular Tachycardia (VT) – This arises from the ventricles and is frequently associated with structural heart disease. 2. Supraventricular Tachycardia (SVT) with Aberrancy – This occurs when an atrial-origin tachycardia presents with a broad QRS complex due to abnormal conduction, such as bundle branch block or accessory pathways (e.g., Wolff-Parkinson-White syndrome).

Key Features to Differentiate VT from SVT with Aberrancy

  • VT is more likely if:
    • Age > 35 years
    • History of ischemic heart disease, heart failure, or cardiomyopathy
    • AV dissociation (atria and ventricles functioning independently)
    • Concordance in precordial leads (all QRS complexes in V1-V6 are positive or negative)
    • QRS duration > 160 ms
  • SVT with aberrancy is more likely if:
    • Previous episodes of SVT
    • Normal heart structure
    • Initiation by sudden atrial tachycardia

Diagnosis and Investigations

  • ECG (Electrocardiogram) is the most important test for classifying BCT.
  • Electrolyte levels (especially potassium and magnesium) should be checked.
  • Echocardiography to assess structural heart disease.
  • Cardiac MRI may be useful in unclear cases.

Management Strategies

Emergency Management (If Unstable Patient)

  • Immediate synchronized cardioversion
  • Advanced cardiac life support (ACLS) protocols

Pharmacological Treatment (Stable Patient)

  1. For VT
    • First-line: Amiodarone (IV infusion)
    • Alternative: Lidocaine, Procainamide (used in specific cases)
  2. For SVT with Aberrancy
    • Adenosine (may reveal underlying SVT if QRS narrows temporarily)
    • Beta-blockers or calcium channel blockers (for rate control)

Long-term Management

  • Implantable Cardioverter Defibrillator (ICD) for high-risk VT patients.
  • Catheter Ablation for recurrent tachyarrhythmias.
  • Lifestyle Modifications (e.g., avoiding triggers, managing hypertension, and heart disease).

Conclusion

Broad Complex Tachycardia is a serious condition requiring rapid evaluation and appropriate management to reduce the risk of fatal arrhythmias. Proper differentiation between VT and SVT with aberrancy is essential for optimal treatment.

Source recommendations

1. American Heart Association (AHA) Guidelines on Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

  1. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000549
  2. https://pubmed.ncbi.nlm.nih.gov/29097320/
  3. https://www.sciencedirect.com/science/article/pii/S2405500X22010945
  4. https://pubmed.ncbi.nlm.nih.gov/29084733/
  5. https://www.hrsonline.org/guidance/clinical-resources/2017-ahaacchrs-guideline-management-patients-ventricular-arrhythmias-and-prevention-sudden-cardiac

2. European Society of Cardiology (ESC) Guidelines for the Management of Supraventricular Tachycardia

  1. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Supraventricular-Tachycardia
  2. https://academic.oup.com/eurheartj/article/41/5/655/5556821
  3. https://pubmed.ncbi.nlm.nih.gov/31504425/
  4. https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2019/09/10/12/36/2019-ESC-Guidelines-for-Supraventricular-Tachycardia
  5. https://pubmed.ncbi.nlm.nih.gov/14563598/

3. ESC Guidelines for the Diagnosis and Management of Ventricular Arrhythmias

  1. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Ventricular-Arrhythmias-and-the-Prevention-of-Sudden-Cardiac-Death
  2. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000549
  3. https://pubmed.ncbi.nlm.nih.gov/26320108/
  4. https://www.jacc.org/doi/10.1016/j.jacep.2022.12.008
  5. https://pubmed.ncbi.nlm.nih.gov/36017572/

Our advantages:

patient2376100
Best practices from USA, EU and Japan
Our answers to your questions are based on the clinical recommendations of countries with the most developed healthcare systems in the field of cardiology in the USA, the EU and Japan.
prescription18648039
Always up-to-date information
On a daily basis, we monitor for you all new scientific research publications in leading scientific journals on medical issues of interest to you.
We monitor all innovations and changes in the field of cardiac disease treatment on a daily basis.
fvfflf7q
Get second opinion
Here you can learn everything that even your doctor may not know about cardiology (if he does not speak English and he does not read 117 leading medical journals on cardiology every month).
1xr4duup
The most comprehensive and up-to-date collection of free cardiology materials
Our website contains the most comprehensive and up-to-date collection of free cardiology materials in your country.
Every 3-5 years, half of the scientific approaches to treatment in the field of cardiology are reviewed as a result of specialized scientific discoveries. With us, you don't have to wait these years to learn about the best ways to treat you and your loved ones.
arrow
Please register in order to receive information regarding possible complications and new approaches to treatment of cardiovascular diseases via email in our Newsletters.
arrow